From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

BBI Solutions to Finalize Development of CDC Anthrax Diagnostic

by Global Biodefense Staff
August 16, 2015
Anthrax Bacteria - Bacillus Anthracis

Anthrax Bacteria - Bacillus Anthracis

The Centers for Disease Control and Prevention (CDC) has announced intentions to issue a sole source contract to BBI Solutions to support optimization of an anthrax toxin diagnostic.

The purpose of this procurement is to advance a lateral flow device diagnostic for anthrax toxin lethal factor from early prototype stage to a device ready for validation. BBI Solutions will optimize the diagnostic to enhance sensitivity, finalize design, define performance characteristics, and prepare for clinical validation.

“Our laboratory scientists provide unique subject matter expertise in B. anthracis microbiology, pathogenicity, and in the prevention, diagnosis and treatment of anthrax,” states the contract announcement. “This procurement will advance our current device from early prototype to a device ready for validation.”

This contract will provide the necessary enhancements to advance the device from prototype to validation-ready device, including activities to:

  • Maximize sensitivity of the devices
  • Identify quality control panel for evaluation of devices
  • Establish final cartridge design
  • Establish data collection and interpretation methods
  • Obtain performance data on assay

Devices from this project are expected to result in a late stage product ready for clinical validation and testing. Data generated will be available for inclusion in an FDA 510(k) submission package.

Source: FBO.gov

From Our Partners
Tags: AnthraxAwardsBioterrorismPOC Diagnostics

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC